Innate Pharma S.A. (NASDAQ:IPHA) Q2 2023 Earnings Conference Call September 14, 2023 8:00 AM ET Company Participants Henry Wheeler - VP, IR & Communication Mondher Mahjoubi - CEO Joyson Karakunnel - Interim Chief Medical Officer Yannis Morel - EVP, BD and Product Portfolio Strategy Frederic Lombard - CFO Conference Call Participants Ashiq Mubarack - Citi Jingming Chen - Evercore ISI Daina Graybosch - Leerink Partners Operator Hello, and welcome to the Innate Pharma First Half 2023 Financial Results and Busi ...